Displaying 13 - 24 of 84
Metabolism, Alcohol & Toxicity

Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity

Opella: MASLD: Early screening, Treatment Strategies, and Quality of Life – Insights from New Clinical Evidence (Complete Sess...

Webcasts
View
Metabolism, Alcohol & Toxicity

MASLD – current treatment  strategies  - from metabolic indices to patient reported outcomes

Webcasts
View
Metabolism, Alcohol & Toxicity

Rising to the Need to Improve Diagnosis in the Era of Disease-specific Therapy

Webcasts
View
Metabolism, Alcohol & Toxicity
Wrap-up

Wrap-up

Webcasts
View
Metabolism, Alcohol & Toxicity
Introduction

Introduction

Webcasts
View
Metabolism, Alcohol & Toxicity
Q&A

Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity
Agile 3+ and Agile 4: two new scores to better identify advanced fibrosis and cirrhosis in NAFLD patients

Agile 3+ and Agile 4: two new scores to better identify advanced fibrosis and cirrhosis in NAFLD patients

Webcasts
View
Metabolism, Alcohol & Toxicity
Clinical cases presentation and discussion

Clinical cases presentation and discussion

Webcasts
View
Metabolism, Alcohol & Toxicity
FAST score for identification of active fibrotic NASH

FAST score for identification of active fibrotic NASH

Webcasts
View
Metabolism, Alcohol & Toxicity
Obesity: what do we need to know and why?

Obesity: what do we need to know and why?

Webcasts
View
Metabolism, Alcohol & Toxicity
Discussion

Discussion

Webcasts
View